Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination.
Anita van de MunckhofKatarzyna KrzywickaDiana Aguiar de SousaMayte Sánchez van KammenMirjam Rachel HeldnerKatarina JoodErik LindgrenTurgut TatlisumakJukka PutaalaJohanna A Kremer HovingaSaskia MiddeldorpMarcel LeviMarcel ArnoldJose M FerroJonathan M CoutinhoPublished in: European journal of neurology (2021)
The reported mortality of CVST with thrombocytopenia after vaccination with adenoviral vector-based SARS-CoV-2 vaccines has significantly decreased over time, which may indicate a beneficial effect of earlier recognition and/or improved treatment on outcome after VITT.